Impact of a pharmacist review service on heart failure patients with reduced ejection fraction between pharmacy residents and Kishan Patel, Ryan Kammer, Zach Klick Novant Health Presbyterian Medical Center - Charlotte, NC
Background/Purpose: Heart failure (HF) is a national epidemic, affecting 5.7 million patients and has a large economic burden, with more than $30 billion in healthcare costs. HF is a condition that results from structural or functional damage of ventricular filling or ejection of blood. In an effort to optimize guideline directed medical therapy, a HF Best Practice computer Alert (BPA) prompting Pharmacist medication review was initiated at Novant Health. The objective of this study is to investigate whether this pharmacy service is beneficial to patient care.
Methodology: This study has been approved by the Institutional Review Board. A multicenter retrospective study will be performed to evaluate overall impact of the heart failure BPA on pharmacists at Novant Health. All acute care Novant Health facilities were included. Patients with a left ventricular ejection fraction (LVEF) less than or equal to 40% hospitalized from April to May and August to September of 2018 were included in the analysis During this time period, pharmacy residents were involved in completing the HF BPA review. This resident data, will be compared to overall review done by staff pharmacists. Data will be collected by reviewing electronic medical records for 200 patients. Descriptive statistics will be used to analyze the data. A complete HF BPA will require documentation of: recent LVEF, assessment of GDMT (ACEI/ARB/ARNI, beta-blocker, aldosterone antagonist therapies), and completed transition of care referral. Pharmacy dosing and monitoring recommendations will be evaluated.
Presentation Objective: Evaluate overall impact of the heart failure triggered alert on patient care for staff pharmacists and pharmacy residents.
Self-Assessment: Is the HF BPA for pharmacists beneficial to optimize patient care?
